Depression, C-Reactive Protein, and the Risk of Mortality During Middle and Late Adulthood.
5 affiliations
- 1College of Health Sciences, Walden University, Minneapolis, MN 55401, USA.
- 2College of Health, Education, and Social Transformation, New Mexico State University, Las Cruces, NM 88003, USA.
- 3Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institute on Aging/NIH/IRP, Baltimore, MD 21224, USA.
- 4Department of Psychiatry and Human Behavior, Thomas Jefferson University, Philadelphia, PA 19107, USA.
- 5Department of Medical Education and Office of Research, Kirk Kerkorian School of Medicine at UNLV, University of Nevada, Las Vegas, NV 89102, USA.
Abstract
Background and Purpose: Mental illnesses, including depression, are major contributors to disability and health loss globally. Research has increasingly focused on identifying biochemical markers, such as C-reactive protein (CRP), to better understand the link between systemic inflammation and psychiatric disorders. However, the long-term health impacts of their coexistence are underexplored. This study aimed to investigate the relationship between depression, elevated CRP levels, and mortality risk among community-dwelling older adults in the United States. Methods: Data from the National Health and Nutrition Examination Survey (NHANES) from 2005-2010 were utilized, linked with mortality data up to December 2019. The sample included 4606 adults aged 50 years and older. Depression was assessed through self-reported measures, and elevated CRP was defined as serum CRP ≥ 2 mg/L. Participants were categorized into four groups: depression only, elevated CRP only, both conditions, or neither. Cox regression models were employed to estimate hazard ratios (HRs) for all-cause and cardiovascular mortality, adjusting for sociodemographic and health-related covariates. Results: Individuals with both depression and elevated CRP had the highest risk of all-cause mortality (HR = 3.56, 95% CI = 1.41-8.97) and cardiovascular mortality (HR = 14.42, 95% CI = 4.29-21.06) compared to those with neither condition. Elevated CRP alone and depression alone were also independently associated with increased mortality risk. Predictors such as age, poverty, smoking, obesity, diabetes, and cardiovascular history significantly influenced these associations. Conclusion: The coexistence of depression and systemic inflammation markedly elevates the risk of mortality. These findings highlight the need for integrated clinical strategies targeting both mental health and inflammation to mitigate mortality risks in vulnerable populations.
Related
- C-reactive protein and mortality in 'SMuRF-less but inflamed' women and men: Evidence from the United Kingdom Biobank
- Prognostic Value of the C-Reactive Protein-to-Albumin Ratio in Patients Hospitalized with Atrioventricular Block: Association with In-Hospital Mortality and Temporary Pacemaker Requirement
- Index-window C-reactive protein and carcinoembryonic antigen and five-year all-cause mortality in Hispanic/Latino and non-Hispanic White patients with colorectal cancer: a retrospective biomarker cohort study.
- C-Reactive Protein-to-Albumin Ratio and Hospital-Recorded Mortality in Patients with ICD-10-Coded Acute Kidney Injury: A Retrospective Cohort Study
- Association of the C-reactive protein-to-HDL cholesterol ratio with all-cause mortality in Chinese adults with impaired renal function: a prospective cohort study
BibTeX
@article{banerjee2026depression,
title = {{Depression, C-Reactive Protein, and the Risk of Mortality During Middle and Late Adulthood.}},
author = {Srikanta Banerjee and Jagdish Khubchandani and May A Beydoun and Stanley Nkemjika and Kavita Batra},
journal = {Epidemiologia (Basel, Switzerland)},
year = {2026},
month = sep,
doi = {10.3390/epidemiologia7050133},
url = {https://europepmc.org/article/MED/42930321},
note = {CC BY},
}
RIS
TY - JOUR
TI - Depression, C-Reactive Protein, and the Risk of Mortality During Middle and Late Adulthood.
AU - Srikanta Banerjee
AU - Jagdish Khubchandani
AU - May A Beydoun
AU - Stanley Nkemjika
AU - Kavita Batra
PY - 2026
DA - 2026/09/26
JO - Epidemiologia (Basel, Switzerland)
DO - 10.3390/epidemiologia7050133
UR - https://europepmc.org/article/MED/42930321
AB - Background and Purpose: Mental illnesses, including depression, are major contributors to disability and health loss globally. Research has increasingly focused on identifying biochemical markers, such as C-reactive protein (CRP), to better understand the link between systemic inflammation and psychiatric disorders. However, the long-term health impacts of their coexistence are underexplored. This study aimed to investigate the relationship between depression, elevated CRP levels, and mortality risk among community-dwelling older adults in the United States. Methods: Data from the National Health and Nutrition Examination Survey (NHANES) from 2005-2010 were utilized, linked with mortality data up to December 2019. The sample included 4606 adults aged 50 years and older. Depression was assessed through self-reported measures, and elevated CRP was defined as serum CRP ≥ 2 mg/L. Participants were categorized into four groups: depression only, elevated CRP only, both conditions, or neither. Cox regression models were employed to estimate hazard ratios (HRs) for all-cause and cardiovascular mortality, adjusting for sociodemographic and health-related covariates. Results: Individuals with both depression and elevated CRP had the highest risk of all-cause mortality (HR = 3.56, 95% CI = 1.41-8.97) and cardiovascular mortality (HR = 14.42, 95% CI = 4.29-21.06) compared to those with neither condition. Elevated CRP alone and depression alone were also independently associated with increased mortality risk. Predictors such as age, poverty, smoking, obesity, diabetes, and cardiovascular history significantly influenced these associations. Conclusion: The coexistence of depression and systemic inflammation markedly elevates the risk of mortality. These findings highlight the need for integrated clinical strategies targeting both mental health and inflammation to mitigate mortality risks in vulnerable populations.
SN - 2673-3986
ER -